Trials / Completed
CompletedNCT04184713
Evaluation of the Effect of an Specific Oral Nutritional Supplement on the Nutritional Status in Cancer and Malnutrition
A Clinical Trial With Nutritional Intervention to Evaluate the Effect of an Specific Oral Nutritional Supplement on the Nutritional Status in Patients With Cancer and Malnutrition
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Instituto de Investigación Hospital Universitario La Paz · Academic / Other
- Sex
- All
- Age
- 28 Years
- Healthy volunteers
- Not accepted
Summary
Effect of a specific nutritional oral supplement on the nutritional status of patients with cancer and malnutrition
Detailed description
Multicentric, parallel, randomized, double blind and controlled clinical-nutritional study of 8 weeks of duration and 2 study groups of treatment: Experimental group (experimental nutritional oral supplement); and Control group (control nutritional oral supplement) to evaluate the effect on the nutritional and functional status, the quality of life and body composition of patients with cancer and malnutrition undergoint specficic treatment (chemotherapy, radiotherapy, inmunotherapy).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Experimental Group | Nutritional intervention and physical activity recommendations. Consumption of 2 tetra paks/day of a specific oral nutritional supplement (hypercaloric/hyperproteic with fiber and omega-3 enriched, with L-leucine, betaglucans and medium chain triglycerides) for 8 weeks. |
| DIETARY_SUPPLEMENT | Control Group | Nutritional intervention and physical activity recommendations. Consumption of 2 tetra paks/day of a specific oral nutritional supplement (hypercaloric/hyperproteic with fiber) for 8 weeks. |
Timeline
- Start date
- 2019-10-01
- Primary completion
- 2020-08-01
- Completion
- 2020-08-01
- First posted
- 2019-12-04
- Last updated
- 2021-07-20
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04184713. Inclusion in this directory is not an endorsement.